Ligand validation:1J21

CIR: CITRULLINE

CIR is a Ligand Of Interest in 1J21 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1J21_CIR_B_1520	37%	35%	0.18	0.879	1.32	1.26	2	1	2	0	100%	1
1J21_CIR_A_520	27%	35%	0.213	0.86	1.3	1.27	2	1	1	0	100%	1
1J21_CIR_C_2520	25%	32%	0.207	0.84	1.35	1.33	3	1	2	0	100%	1
1J21_CIR_D_3520	21%	33%	0.24	0.848	1.25	1.38	2	2	1	0	100%	1
1J1Z_CIR_A_520	53%	29%	0.136	0.898	1.45	1.37	2	1	1	0	100%	1
4GVY_CIR_A_403	87%	23%	0.085	0.957	1.66	1.49	2	3	0	0	100%	1
1LXY_CIR_B_500	80%	0%	0.118	0.968	5.78	8.9	3	4	0	0	100%	1
2C6Z_CIR_A_1281	76%	18%	0.11	0.946	0.88	2.6	1	3	0	0	100%	1
2NZ2_CIR_A_502	66%	45%	0.139	0.945	0.88	1.25	-	2	2	0	100%	1
4JQO_CIR_A_402	64%	29%	0.138	0.938	1.15	1.67	-	3	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.